Found: 81
Select item for more details and to access through your institution.
Pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization: a prospective randomized study for optimal apheresis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of lanreotide in Korean patients with metastatic, well-differentiated gastroenteropancreatic-neuroendocrine tumors: a retrospective analysis.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 4, p. 763, doi. 10.1007/s10637-018-0710-x
- By:
- Publication type:
- Article
Prognostic factors in patients with metastatic or recurrent pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine: implication of inflammation-based scores.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 3, p. 584, doi. 10.1007/s10637-018-0681-y
- By:
- Publication type:
- Article
Phase I study of CKD-581, a pan-histone deacetylase inhibitor, in patients with lymphoma or multiple myeloma refractory to standard therapy.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 877, doi. 10.1007/s10637-018-0582-0
- By:
- Publication type:
- Article
Nab-paclitaxel plus gemcitabine versus FOLFIRINOX as the first-line chemotherapy for patients with metastatic pancreatic cancer: retrospective analysis.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 4, p. 732, doi. 10.1007/s10637-018-0598-5
- By:
- Publication type:
- Article
Prognostic Implication of Inflammation-based Prognostic Scores in Patients with Intrahepatic Cholangiocarcinoma Treated with First-line Gemcitabine plus Cisplatin.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 3, p. 496, doi. 10.1007/s10637-017-0548-7
- By:
- Publication type:
- Article
Germline <italic>BRCA</italic> mutations in Asian patients with pancreatic adenocarcinoma: a prospective study evaluating risk category for genetic testing.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 1, p. 163, doi. 10.1007/s10637-017-0497-1
- By:
- Publication type:
- Article
First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies.
- Published in:
- Investigational New Drugs, 2015, v. 33, n. 5, p. 1048, doi. 10.1007/s10637-015-0262-2
- By:
- Publication type:
- Article
Erratum to: Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab.
- Published in:
- 2015
- By:
- Publication type:
- Erratum
NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutants.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 3, p. 389, doi. 10.1007/s10637-013-0039-4
- By:
- Publication type:
- Article
Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 3, p. 535, doi. 10.1007/s10637-014-0065-x
- By:
- Publication type:
- Article
A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 2, p. 369, doi. 10.1007/s10637-013-0059-0
- By:
- Publication type:
- Article
A phase I study of DHP107, a mucoadhesive lipid form of oral paclitaxel, in patients with advanced solid tumors: Crossover comparisons with intravenous paclitaxel.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 3, p. 616, doi. 10.1007/s10637-012-9841-7
- By:
- Publication type:
- Article
Multicenter phase II study of second-line bevacizumab plus doublet combination chemotherapy in patients with metastatic colorectal cancer progressed after upfront bevacizumab plus doublet combination chemotherapy.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 1, p. 183, doi. 10.1007/s10637-012-9853-3
- By:
- Publication type:
- Article
Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory and KRAS wild-type metastatic colorectal cancer according to epidermal growth factor receptor expression status.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1607, doi. 10.1007/s10637-011-9703-8
- By:
- Publication type:
- Article
A phase I study of S-1 treatment with a 3 week schedule in advanced biliary cancer patients with or without hepatic dysfunction.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 2, p. 332, doi. 10.1007/s10637-009-9378-6
- By:
- Publication type:
- Article
CT-determined resectability of borderline resectable and unresectable pancreatic adenocarcinoma following FOLFIRINOX therapy.
- Published in:
- European Radiology, 2021, v. 31, n. 2, p. 813, doi. 10.1007/s00330-020-07188-8
- By:
- Publication type:
- Article
Multiparametric MRI for prediction of treatment response to neoadjuvant FOLFIRINOX therapy in borderline resectable or locally advanced pancreatic cancer.
- Published in:
- European Radiology, 2021, v. 31, n. 2, p. 864, doi. 10.1007/s00330-020-07134-8
- By:
- Publication type:
- Article
Clinical impact of preoperative liver MRI in the evaluation of synchronous liver metastasis of colon cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 10, p. 2734, doi. 10.3390/cells10102734
- By:
- Publication type:
- Article
Estimation of population-based utility weights for gastric cancer-related health states.
- Published in:
- Patient Preference & Adherence, 2018, v. 12, p. 909, doi. 10.2147/PPA.S151946
- By:
- Publication type:
- Article
Prognostic Value of the Microsatellite Instability Status in Patients With Stage II/III Rectal Cancer Following Upfront Surgery.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Epidemiology and Outcomes of Non–Small Cell Lung Cancer in South Korea.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 2, p. e2355331, doi. 10.1001/jamanetworkopen.2023.55331
- By:
- Publication type:
- Article
Assessment of the Analgesic Effect of Remifentanil using Three Pain Models in Healthy Korean Volunteers: A Randomized, Controlled Study.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2012, v. 110, n. 6, p. 518, doi. 10.1111/j.1742-7843.2011.00849.x
- By:
- Publication type:
- Article
Expression of HER2 and Mismatch Repair Proteins in Surgically Resected Gallbladder Adenocarcinoma.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.658564
- By:
- Publication type:
- Article
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular‐cholangiocarcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 6, p. 1398, doi. 10.1111/liv.14813
- By:
- Publication type:
- Article
Prediction of margin‐negative resection of pancreatic ductal adenocarcinoma following neoadjuvant therapy: Diagnostic performance of NCCN criteria for resection vs CT‐determined resectability.
- Published in:
- Journal of Hepato -- Biliary -- Pancreatic Sciences, 2022, v. 29, n. 9, p. 1025, doi. 10.1002/jhbp.1192
- By:
- Publication type:
- Article
Real-world outcomes of adjuvant gemcitabine versus gemcitabine plus capecitabine for resected pancreatic ductal adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221097190
- By:
- Publication type:
- Article
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211003053
- By:
- Publication type:
- Article
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Disease severity-based evaluation of utility weights for lung cancer-related health states in Korea.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 2, p. 469, doi. 10.1007/s10549-017-4516-x
- By:
- Publication type:
- Article
Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis.
- Published in:
- Gastric Cancer, 2017, v. 20, n. 6, p. 970, doi. 10.1007/s10120-017-0710-0
- By:
- Publication type:
- Article
A Phase I Study of UGT1A1 *28/*6 Genotype-Directed Dosing of Irinotecan (CPT-11) in Korean Patients with Metastatic Colorectal Cancer Receiving FOLFIRI.
- Published in:
- Oncology, 2015, v. 88, n. 3, p. 164, doi. 10.1159/000368674
- By:
- Publication type:
- Article
TFAP2E Methylation Status and Prognosis of Patients with Radically Resected Colorectal Cancer.
- Published in:
- Oncology, 2015, v. 88, n. 2, p. 122, doi. 10.1159/000362820
- By:
- Publication type:
- Article
Single-Nucleotide Polymorphisms in the Vascular Endothelial Growth Factor Pathway and Outcomes of Patients Treated with First-Line Cytotoxic Chemotherapy Combined with Bevacizumab for Advanced Colorectal Cancer.
- Published in:
- Oncology, 2014, v. 87, n. 5, p. 280, doi. 10.1159/000365593
- By:
- Publication type:
- Article
A Phase II Study of Clinical Outcomes of 3-Week Cycles of Irinotecan and S-1 in Patients with Previously Untreated Metastatic Colorectal Cancer: Influence of the UGT1A1 and CYP2A6 Polymorphisms on Clinical Activity.
- Published in:
- Oncology, 2012, v. 82, n. 5, p. 290, doi. 10.1159/000337989
- By:
- Publication type:
- Article
Genetic Polymorphisms of FcγRIIa and FcγRIIIa Are Not Predictive of Clinical Outcomes after Cetuximab plus Irinotecan Chemotherapy in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 83, doi. 10.1159/000335959
- By:
- Publication type:
- Article
S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3‐mediated programmed death‐ligand 1 expression in colorectal cancer.
- Published in:
- Clinical & Translational Medicine, 2022, v. 12, n. 7, p. 1, doi. 10.1002/ctm2.986
- By:
- Publication type:
- Article
Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular–cholangiocarcinoma.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 10, p. 7547, doi. 10.1007/s00432-023-04704-3
- By:
- Publication type:
- Article
Comparison of the different versions of NCCN guidelines for predicting margin-negative resection of pancreatic cancer in patients undergoing upfront surgery.
- Published in:
- Abdominal Radiology, 2024, v. 49, n. 8, p. 2737, doi. 10.1007/s00261-024-04299-4
- By:
- Publication type:
- Article
Atezolizumab Plus PEGPH20 Versus Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma and Gastric Cancer: MORPHEUS Phase Ib/II Umbrella Randomized Study Platform.
- Published in:
- Oncologist, 2023, v. 28, n. 6, p. 553, doi. 10.1093/oncolo/oyad022
- By:
- Publication type:
- Article
Efficacy and Safety of FOLFIRI Regimen in Elderly Patients with Metastatic Colorectal or Gastric Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 3, p. 293, doi. 10.1634/theoncologist.2016-0166
- By:
- Publication type:
- Article
Clinical outcomes of liposomal irinotecan plus fluorouracil/leucovorin for metastatic pancreatic adenocarcinoma in patients previously treated with conventional irinotecan-containing chemotherapy.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211003053
- By:
- Publication type:
- Article
FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920953294
- By:
- Publication type:
- Article
Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920923424
- By:
- Publication type:
- Article
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835919871126
- By:
- Publication type:
- Article
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study Group.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919871126
- By:
- Publication type:
- Article
Radiation therapy for recurrent extrahepatic bile duct cancer.
- Published in:
- PLoS ONE, 2021, v. 16, n. 6, p. 1, doi. 10.1371/journal.pone.0253285
- By:
- Publication type:
- Article